Manufacturing · FDA 21 CFR Part 11 / Annex 11 Compliance

Inventory every GxP system, classify by risk, validate, and stand up audit-trail review — zero observation findings on next inspection.

Frequently asked questions

What does the Manufacturing · FDA 21 CFR Part 11 / Annex 11 Compliance blueprint do?

Inventory every GxP system, classify by risk, validate, and stand up audit-trail review — zero observation findings on next inspection.

What KPIs does the Manufacturing blueprint target?

GxP Systems Inventoried from 60 to 100 (weekly). Systems With Validation State from 55 to 100 (weekly). High-Risk Systems With Daily Review from 20 to 100 (weekly).

How long does the Manufacturing · FDA 21 CFR Part 11 / Annex 11 Compliance deployment take?

12 weeks.

What systems does the Manufacturing blueprint integrate with?

Integrates with Validated MES / QMS, Audit-trail review tooling, IAM / SSO with audit logs through the AEROSS Execution Mesh. All writes are credit-metered, CAPS-gated, and audit-stamped.

What regulatory requirements does this blueprint address?

FDA 21 CFR Part 11 — Electronic Records & Signatures; EU GMP Annex 11 — Computerised Systems; GAMP 5 v2 risk-based validation All agent actions inherit AEROSS CAPS governance — autonomy ceilings, human approval gates, and a tamper-evident audit log.